For Immediate Release CoMeD President [Rev. Lisa K. Sykes (Richmond, VA) 804-364-8426]
November 28, 2007 CoMeD Sci. Advisor [Dr. King (Lake Hiawatha, NJ) 973-263-4843]
WASHINGTON, DC – A new moderate-scale peer-reviewed scientific/medical study confirms many patients with an autistic spectrum disorder (ASD) suffer from significantly elevated levels of male hormones, and numerous treatments that lower male-hormone levels have significantly improved clinical outcomes in patients with an ASD.
This study, “A Prospective Assessment of Androgen Levels in Patients with Autistic Spectrum Disorders: Biochemical Underpinnings and Suggested Therapies,” by Mr. David A. Geier and Dr. Mark R. Geier, has been published in the most recent issue of Neuroendocrinology Letters (Volume 28, Issue 5, pgs. 565-573). A grant from the Brenen Hornstein Autism Research & Education (BHARE) Foundation (Elk Grove, IL) to the Institute of Chronic Illnesses, Inc. (Silver Spring, MD) funded this research.[Continue reading...]